John Hemmersmeier

Statistics

Publications

Citations

117

H-Index

Active since

2001

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

John Hemmersmeier is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in infectious diseases, veterinary medicine, and vaccination.

Publications per year

2001–2025

Publications

Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial

Heather Platt, Christopher Bruno, Erik Buntinx et al. · The Lancet Infectious Diseases · 2024 · 53 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Breast cancer after mantle irradiation for Hodgkin’s disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2

David K. Gaffney, John Hemmersmeier, Joseph A. Holden et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 47 citations

Medicine, Oncology, Pathology +17

Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase

Amanda K. Rudman Spergel, Ivan T. Lee, Kindra Koslovsky et al. · Nature Communications · 2025 · 17 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–3 of 3